Your browser doesn't support javascript.
loading
Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction.
Reddy, Yogesh N V; Melenovsky, Vojtech; Asokan, Aneesh K; Haluzik, Martin; Carter, Rickey E; Nair, Sreekumaran; Jensen, Michael D; Borlaug, Barry A.
Afiliación
  • Reddy YNV; The Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
  • Melenovsky V; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
  • Asokan AK; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN, USA.
  • Haluzik M; Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.
  • Carter RE; Department of Quantitative Health Sciences, Division of Clinical Trials & Biostatistics, Mayo Clinic, Jacksonville, FL, USA.
  • Nair S; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN, USA.
  • Jensen MD; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN, USA.
  • Borlaug BA; The Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.
Eur Heart J ; 2024 Aug 21.
Article en En | MEDLINE | ID: mdl-39167062
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eur Heart J Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos